Nanoparticulate Drug Delivery Systems for the Treatment of Atherosclerosis
Mentor Information
Yashwant Pathak (Taneja College of Pharmacy)
Description
Nanotechnology is at the forefront of medical technology. It has a vast number of applications in the health sciences and new breakthroughs are being made constantly using it. Recently, Nanotechnology has been a candidate for new ways to deliver drugs in order to treat this heart condition. The purpose of this research article is to shed light on recent developments in Nanotechnology by analyzing its recent real-world applications to treat Atherosclerosis. Traditional methods of treatment including medication, lifestyle changes, and even invasive surgeries. Oral medication and surgical procedures have proven to be successful in treating Atherosclerosis, but both can cause tissue damages and other problems. Nanotechnology can be used to deliver drugs and even help improve white blood cell responses to plaque buildup. The usage of liposomes developed with nanotechnology helped increase the solubility of statins which helped increase absorption and bioavailability. When the medication was placed inside the developed liposome, it was shielded until it reached the target site. The biochemical properties of liposomes have helped researchers attach biomolecules like antibodies to the liposomes in order to help with targeting, guiding, and attracting macrophages to areas of interest like plaque sites. Another nanotechnology that is being further developed for a medical application is carbon nanotubes. These nanotubes can be easily grown and have been used successfully to deliver drugs and create nano-scaffolding to help tissue growth. Nanotechnology has enormous potential for medicine and when applied to the heart condition Atherosclerosis, nanotechnology has been able to prove its usefulness successfully.
Nanoparticulate Drug Delivery Systems for the Treatment of Atherosclerosis
Nanotechnology is at the forefront of medical technology. It has a vast number of applications in the health sciences and new breakthroughs are being made constantly using it. Recently, Nanotechnology has been a candidate for new ways to deliver drugs in order to treat this heart condition. The purpose of this research article is to shed light on recent developments in Nanotechnology by analyzing its recent real-world applications to treat Atherosclerosis. Traditional methods of treatment including medication, lifestyle changes, and even invasive surgeries. Oral medication and surgical procedures have proven to be successful in treating Atherosclerosis, but both can cause tissue damages and other problems. Nanotechnology can be used to deliver drugs and even help improve white blood cell responses to plaque buildup. The usage of liposomes developed with nanotechnology helped increase the solubility of statins which helped increase absorption and bioavailability. When the medication was placed inside the developed liposome, it was shielded until it reached the target site. The biochemical properties of liposomes have helped researchers attach biomolecules like antibodies to the liposomes in order to help with targeting, guiding, and attracting macrophages to areas of interest like plaque sites. Another nanotechnology that is being further developed for a medical application is carbon nanotubes. These nanotubes can be easily grown and have been used successfully to deliver drugs and create nano-scaffolding to help tissue growth. Nanotechnology has enormous potential for medicine and when applied to the heart condition Atherosclerosis, nanotechnology has been able to prove its usefulness successfully.
